Treatment Algorithms for Hormone Receptor–Positive Advanced Breast Cancer: Going Forward in Endocrine Therapy—Overcoming Resistance and Introducing New Agents ER+ breast cancers can exhibit de novo or ...

Emerging evidence ties endocrine-disrupting chemical exposure to two of the biggest public health threats facing society -- diabetes and obesity. EDCs contribute to health problems by mimicking, ...

Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial The approval was ...

More than 70% of women with metastatic breast cancer have hormone-receptor positive disease. Resistance to endocrine therapies in this population is common and problematic. Minimizing resistance to ...